Africa (WHO region) vs Oman: HIV-positive TB patients on ART (antiretroviral therapy)
Africa (WHO region)
96.0%
in 2024
Oman
100.0%
in 2024
Africa (WHO region) rank
2nd
Oman rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Africa (WHO region)
- Oman
How they compare
Oman currently reports 100.0% against 96.0% in Africa (WHO region), a difference of 4.0%.
The two have swapped places 6 times across 21 shared years of data; in 2003 it was Oman ahead.
Africa (WHO region) ranks 2nd and Oman ranks 1st of 11 groups.
Across the 3 decades both report, Africa (WHO region) averaged higher in 1 and Oman in 2.
Head to head by decade
| Decade | Africa (WHO region) | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 30.0% | 100.0% | 70.0% | Oman |
| 2010s | 74.3% | 93.1% | 18.8% | Oman |
| 2020s | 93.2% | 91.4% | 1.8% | Africa (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Africa (WHO region) or Oman?
- Oman, at 100.0% against 96.0% in Africa (WHO region) as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Africa (WHO region) and Oman?
- 4.0%, with Oman ahead.
- How many years of comparable data are there for Africa (WHO region) and Oman?
- 21 years are reported by both, from 2003 to 2024.
- How do Africa (WHO region) and Oman rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Africa (WHO region) ranks 2nd and Oman ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.